ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Systemic sclerosis"

  • Abstract Number: 1070 • 2019 ACR/ARP Annual Meeting

    Cytokine Signatures Differentiate Systemic Sclerosis Patients at High versus Low Risk for Pulmonary Arterial Hypertension

    Kathleen Kolstad1, Avani Khatri 2, Michele Donato 3, Sarah Chang 4, Shufeng Li 5, Virginia Steen 6, Paul Utz 4, Purvesh Khatri 3 and Lorinda Chung 7, 1Division of Immunology and Rheumatology, Department of Medicine, Stanford University, Stanford, CA, 2Institute for Immunity, Transplantation and Infection, Stanford University, Stanford, 3Institute for Immunity, Transplantation and Infection, Stanford University, Palo Alto, 4Division of Immunology and Rheumatology, Department of Medicine, Stanford, Palo Alto, 5Division of Immunology and Rheumatology, Department of Medicine, Stanford, Palo Alto, CA, 6Georgetown University, Washington, D.C., USA, Georgetown, 7Stanford University, Palo Alto, CA

    Background/Purpose: Pulmonary arterial hypertension (PAH) affects approximately 10% of patients with systemic sclerosis (SSc) and is a leading cause of death. Screening algorithms using clinical…
  • Abstract Number: 1654 • 2019 ACR/ARP Annual Meeting

    Esophageal Dilation and Other Clinical Factors Associated with Pulmonary Function Decline in Patients with Systemic Sclerosis

    Kimberly Showalter1, Aileen Hoffmann 2, Carrie Richardson 3, Kimberly Koloms 2, Gerald Rouleau 2, David Aaby 2, Julia (Jungwha) Lee 4, Jane Dematte 2, Rishi Agrawal 2, Xiaoping Wu 5, Rowland Chang 4 and Monique Hinchcliff 6, 1Hospital for Special Surgery, New York, NY, 2Northwestern University Feinberg School of Medicine, Chicago, 3Rush University, Chicago, 4Northwestern University Feinberg School of Medicine, Chicago, IL, 5New York Presbyterian/Weill Cornell, New York, 6Yale University, Section of Rheumatology, Allergy and Immunology, New Haven, CT

    Background/Purpose: Prior work has shown that Scl-70 positive autoantibody status and baseline c-reactive protein (CRP) are associated with more rapid pulmonary function decline in patients…
  • Abstract Number: 2596 • 2019 ACR/ARP Annual Meeting

    The Contribution of Left Heart Disease in Patients with Systemic Sclerosis-associated Pulmonary Hypertension Having Normal Pulmonary Artery Wedge Pressure

    Yoshioki Yamasaki1, Kanako Suzuki 1, Keiichi Sakurai 2, Yusa Asari 1, Hidehiro Yamada 3 and Kimito Kawahata 2, 1Rheumatology and Allergology, St. Marianna University School of Medicine, Kawasaki, Japan, 2Rheumatology and Allergology, St. Marianna University School of Medicine, Tokyo, Japan, 3Center for Rheumatic diseases, Seirei Yokohama Hospital, Kawasaki, Japan

    Background/Purpose: Patients with systemic sclerosis (SSc) complicates variety of cardiopulmonary diseases which can result in pulmonary hypertension (PH). The types of PH are usually classified…
  • Abstract Number: 2618 • 2019 ACR/ARP Annual Meeting

    Anti-RNPC-3 Antibodies Are Associated with Nuclear Speckled Immunofluorescence Pattern and Enriched in Triple Negative Systemic Sclerosis Patients

    Michael Mahler1, Fabrece Roup 1, Chelsea Bentow 1, Marie Hudson 2, Murray Baron 3, May Choi 4 and Marvin Fritzler 5, 1Inova Diagnostics, San Diego, CA, 2Jewish General Hospital, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University, Montreal, QC, Canada, 3Jewish General Hospital, McGill University, Montreal, Canada, 4Cumming School of Medicine, University of Calgary, Calgary, Canada, 5Cumming School of Medicine, University of Calgary, Calgary, AB, Canada

    Background/Purpose: Anti-nuclear antibodies (ANA) are present in approximately 90% of sera from systemic sclerosis (SSc) patients and play an important diagnostic and prognostic role in…
  • Abstract Number: 18 • 2019 ACR/ARP Annual Meeting

    Undifferentiated Connective Tissue Disease at Risk for SSc: Potential Role of Circulating CXCL-10, CXCL-11 and IL-33 in Predicting Disease Evolution

    Antonella Riccardi1, Alessia Borgia 2, Serena Fasano 1, Valentina Messiniti 3, Rosaria Irace 3 and Gabriele Valentini 4, 1Rheumatology Unit, Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, Naples, Italy, Naples, Italy, 2University of Campania L. Vanvitelli, Naples, Italy, 3Rheumatology Unit, Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, Naples, Italy, Naples, 4Dipartimento di Medicina di Precisione, II Policlinico U.O. Reumatologia, Napoli, Italy, Napoli, Italy

    Background/Purpose: Higher levels of CXCL10 and CXCL11 in patients with a very early diagnosis of systemic sclerosis (SSc) subsequently shifted to SSc were pointed out…
  • Abstract Number: 726 • 2019 ACR/ARP Annual Meeting

    Digital Blood Perfusion Differences Between Black Africans and Caucasians with Systemic Sclerosis

    Claudia Ickinger1, Valerie Lambrecht 2, Eustasius Musenge 3, Mohammed Tikly 1, Maurizio Cutolo 4 and Vanessa Smith 5, 1Division of Rheumatology, Chris Hani Baragwanath Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, Joahnnesburg, South Africa, 2Department of Rheumatology, Ghent University Hospital, Ghent, Belgium, 3School of Public Health, University of the Witwatersrand, Johannesburg, South Africa, 4Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS Ospedale Policlinico San Martino, Genoa, Italy, Genoa, Italy, 5Dept. of Rheumatology, Ghent University Hospital, Ghent, Belgium; Dept. of Internal Medicine, Ghent University, Ghent, Belgium; Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Center (IRC), Ghent, Belgium, Gent, Belgium

    Background/Purpose: Microvascular dysfunction is a prominent feature in SSc. Laser speckle contrast analysis (LASCA) has been shown to be a reliable tool to quantify skin…
  • Abstract Number: 1043 • 2019 ACR/ARP Annual Meeting

    The Metabolic Intermediate Alpha-Ketoglutarate Suppresses the TGFβ-driven Profibrotic Responses of Dermal Fibroblasts

    Blaž Burja1, Gabriela Kania 2, Matija Tomšič 3, Tea Janko 3, Snezna Sodin-Semrl 3, Oliver Distler 4, Katja Lakota 3 and Mojca Frank-Bertoncelj 5, 1Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, Zurich, Switzerland, 2Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 3Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, LJUBLJANA, Slovenia, 4Dept. of Rheumatology, University Hospital Zürich, Zürich, Switzerland, Zürich, Switzerland, 5University Hospital Zürich, Zürich, Switzerland

    Background/Purpose: Metabolic perturbations are emerging as drivers of fibroblast activation in fibrosis. Transcriptomic analyses have shown the enrichment of glycolysis and suppression of tricarboxylic acid…
  • Abstract Number: 1072 • 2019 ACR/ARP Annual Meeting

    CCR2+ Circulating Monocytes Contribute to the Survival of ADSC in Bleomycin-Induced Skin Fibrosis

    Madhavi Latha Chalasani1, Liyoung Kim 1 and Theresa Lu 2, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Weill Cornell Medicine (Microbiology and Immunology), New York

    Background/Purpose: Monocytes and monocyte-derived cells play a crucial role during homeostasis and also during the development of various inflammatory diseases including skin fibrosis. Ly6Chi inflammatory…
  • Abstract Number: 1655 • 2019 ACR/ARP Annual Meeting

    Histologic Features Correlate with the Modified Rodnan Skin Score, Serum Inflammatory Markers, and Patient Reported Outcomes in Patients with Early, Diffuse Cutaneous Systemic Sclerosis

    Kimberly Showalter1, Cynthia Magro 2, Dana Orange 3, Yaxia Zhang 4, Phaedra Agius 5, Jackie Finik 6, Robert Spiera 1 and Jessica Gordon 1, 1Hospital for Special Surgery, New York, NY, 2Weill Cornell Medicine, New York, 3Rockefeller University, New York, 4Hospital for Special Surgery, New York, 5New York Genome Center, New York City, 6Hospital for Special Surgery, New York, NY, New York, NY

    Background/Purpose: The association between systemic sclerosis (SSc) skin histology and clinical findings is not fully characterized. In two SSc trials, we developed a scoring system…
  • Abstract Number: 2597 • 2019 ACR/ARP Annual Meeting

    Prevalence and Clinical Associations of Degos Lesions in Systemic Sclerosis

    Paula Song1, Melody Chung 2, Shufeng Li 3, David Fiorentino 4 and Lorinda Chung 2, 1Department of Medicine, Santa Clara Valley Medical Center, Palo Alto, CA, 2Stanford University, Palo Alto, CA, 3Division of Immunology and Rheumatology, Department of Medicine, Stanford, Palo Alto, CA, 4Department of Dermatology, Stanford University School of Medicine, Redwood City, CA

    Background/Purpose: Degos disease, also known as malignant atrophic papulosis (MAP), is a rare small-vessel vasculopathy that has characteristic cutaneous manifestations consisting of erythematous telangiectatic rims…
  • Abstract Number: 2744 • 2019 ACR/ARP Annual Meeting

    Altered Expression of CD52 Facilitates Adhesion of Circulating CD14+ Monocytes in Systemic Sclerosis

    Michal Rudnik1, Mara Stellato 1, Filip Rolski 2, Przemyslaw Blyszczuk 3, Karin Klingel 4, Joerg Henes 5, Carol Feghali-Bostwick 6, Oliver Distler 7 and Gabriela Kania 3, 1Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 2Department of Clinical Immunology, Jagiellonian University Medical College, Krakow, Poland, 3Centre of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 4Institute for Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany, 5University Hospital Tuebingen, Department of Internal Medicine II (Oncology, Haematology, Immunology and Rheumatology), Tuebingen, Germany, 6Division of Rheumatology & Immunology, Medical University of South Carolina, Charlston, SC, 7Dept. of Rheumatology, University Hospital Zürich, Zürich, Switzerland, Zürich, Switzerland

    Background/Purpose: Infiltration of inflammatory cells, including monocytes, into the organs is a major process leading to fibrosis, remodelling and organ dysfunction in systemic sclerosis (SSc).…
  • Abstract Number: 262 • 2019 ACR/ARP Annual Meeting

    Outpatient Healthcare Utilization Among Incident Cases of Systemic Sclerosis: Results from a Population-based Cohort (1988-2016)

    Caitrin Coffey1, Avneek Singh Sandhu 2, Cynthia Crowson 3, Dennis Asante 1, Eric Matteson 4, Thomas Osborn 5, Kenneth Warrington 6 and Ashima Makol 5, 1Mayo Clinic, Rochester, MN, 2kettering health, dayton, OH, 3Mayo Clinic Rochester, Rochester, 4Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA, Rochester, 5Mayo Clinic Minnesota, rochester, MN, 6Mayo Clinic Rochester, Rochester, MN

    Background/Purpose: Systemic sclerosis (SSc) is a chronic autoimmune disorder which results in multi-organ dysfunction and high morbidity and mortality. There is limited data on healthcare…
  • Abstract Number: 727 • 2019 ACR/ARP Annual Meeting

    Mortality and Morbidity in Scleroderma Renal Crisis: A Systematic Literature Review

    Hyein Kim1, Frédéric Lefebvre 2, Sabrina Hoa 3 and Marie Hudson 4, 1The University of British Columbia, Vancouver, Canada, 2University of Montreal, Montreal, Canada, 3University of Montreal, Montreal, QC, Canada, 4Jewish General Hospital, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University, Montreal, QC, Canada

    Background/Purpose: The introduction of angiotensin converting enzyme (ACE) inhibitors in the early 1970s resulted in marked improvement in clinical outcomes of scleroderma renal crisis (SRC).Despite…
  • Abstract Number: 1044 • 2019 ACR/ARP Annual Meeting

    TGF-β Isoforms Modulate the RNA Cargo of Extracellular Vesicles (Exosomes) Isolated from Cultured Normal Human Lung Microvascular Endothelial Cells: A Mechanistic Link Between Endothelial Cell Dysfunction and the Establishment of a Profibrotic Phenotype in SSc?

    Peter Wermuth1 and Sergio Jimenez 1, 1Jefferson Institute of Molecular Medicine and Division of Connective Tissue Diseases, Thomas Jefferson University, Philadelphia, PA, Philadelphia, PA

    Background/Purpose: Extracellular vesicles (EV) are a diverse assortment of lipid bilayer-bound vesicles of various sizes and origin. Exosomes are a subset of EV arising from…
  • Abstract Number: 1629 • 2019 ACR/ARP Annual Meeting

    Significance of Abnormal Nailfold Videocapillarscopy Among Patients with Raynaud’s Phenomenon And/or Suspected Connective Tissue Disease: A Cross-Sectional Single-Center US Experience

    Yasser Radwan1, Tina Gunderson 2, Cynthia Crowson 3, Alicia Hinze 1, Kevin Moder 4, Floranne Ernste 4, Shreyasee Amin 4, Uma Thanarajasingam 2, Thomas Osborn 1, Kenneth Warrington 4, Paul Wennberg 4 and Ashima Makol 1, 1Mayo Clinic Minnesota, rochester, MN, 2Mayo Clinic, Rochester, MN, 3Mayo Clinic Rochester, Rochester, 4Mayo Clinic Rochester, rochester, MN

    Background/Purpose: Nailfold videocapillaroscopy (NVC) is a simple, non-invasive & highly sensitive tool to evaluate structural abnormalities of the microcirculation in vivo and considered a key…
  • « Previous Page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • …
  • 46
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology